ELDN
NASDAQ
$3.86
Eledon Pharmaceuticals Inc (ELDN)
Eledon Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing drugs for patients living with autoimmune diseases and amyotrophic lateral sclerosis (ALS) who require organ or cell transplantation. The company is headquartered in Irvine, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $9 (+133.16%)
Market Cap
$305M
FCF 5Y CAGR
+47.56%
Free Cash Flow Yield
-23.24%
Beta (5Y)
1.36
Price Chart
Valuation
Market Cap$305M
Forward P/E5.39
P/B6.98
Profitability
EBITDA-$74M
EPS-$1.10
Financial Health
Free Cash Flow Yield-23.24%
Growth & Risk
EPS 5Y CAGR-4.22%
FCF 5Y CAGR+47.56%
Beta (5Y)1.36
Sharpe Ratio0.51